Innospec (NASDAQ:IOSP) Sets New 52-Week Low – Should You Sell?

Innospec Inc. (NASDAQ:IOSP)’s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as $71.82 and last traded at $73.65, with a volume of 209864 shares trading hands. The stock had previously closed at $73.58.

Analyst Ratings Changes

Several research firms have recently commented on IOSP. Weiss Ratings downgraded Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday, October 25th. Zacks Research raised Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Wall Street Zen downgraded Innospec from a “buy” rating to a “hold” rating in a research report on Sunday, October 19th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Innospec Price Performance

The firm has a market cap of $1.83 billion, a price-to-earnings ratio of 94.42 and a beta of 1.04. The stock has a 50-day moving average of $79.26 and a 200-day moving average of $83.61.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.09. The business had revenue of $439.70 million for the quarter, compared to the consensus estimate of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.39 earnings per share. On average, equities analysts expect that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Institutional Investors Weigh In On Innospec

A number of large investors have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC grew its position in Innospec by 8.8% during the third quarter. Nisa Investment Advisors LLC now owns 1,917 shares of the specialty chemicals company’s stock worth $148,000 after buying an additional 155 shares in the last quarter. State of Wyoming grew its position in Innospec by 27.5% during the second quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock worth $67,000 after buying an additional 173 shares in the last quarter. California State Teachers Retirement System grew its position in Innospec by 0.8% during the second quarter. California State Teachers Retirement System now owns 23,062 shares of the specialty chemicals company’s stock worth $1,939,000 after buying an additional 179 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after purchasing an additional 186 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Innospec by 4.2% in the 1st quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company’s stock valued at $482,000 after purchasing an additional 207 shares in the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.